Study of the Effect of Aristolochic Acid on Mice Kidney and the Effect of Withdrawal: Histological and Immunohistochemical Study
Received Date: Feb 21, 2018 / Accepted Date: Apr 02, 2018 / Published Date: Apr 06, 2018
Aristolochic acid (AA), one of the commonly used herbal medicines was reported to cause harmful effect on kidney. In this work, we aimed to study the effect of AA on renal tissue and to investigate the effect of its withdrawal. Methods: Forty five adult male mice were randomly assigned to three groups. Control group, Group 1 where mices were treated with aristolochic acid (AA) i.p. in a dose of 3 mg/kg every 3 days for 6 weeks. In group 2 the (remodeling group), AA was administered i.p. in a dose of 3 mg/kg every 3 days for 6 weeks, followed by 6 weeks remodeling (withdrawal) time. Urine and blood samples were collected; creatinine, BUN and P/C ratio were estimated. Renal specimens were processed for histological examination by H&E, Masson trichrome and immunohistochemical stain for PCNA. Results: in group 1 treated with AA, histological examination revealed that some tubules were atrophied collapsed while others were dilated. Tubular cells exhibited cytoplasmic vacuolation, flattening, necrosis and even shedding. The matrix between tubules was expanded. In the surrounding interstitial areas, mononuclear cell infiltration was observed. Tubulointerstitial cell proliferation was significantly increased as indicated by PCNA immunostaining. This correlates with worsening of renal parameters. However, in group 2, withdrawal of AA led to marked improvement of renal parameters, preservation of renal tissue and reduction of tubular damage and cellular infiltrate. Also, the number of PCNA-positive cells was significantly reduced. In conclusion, aristolochic acid is nephrotoxic and cessation of its administration leads to reduction of this toxicity as was evidenced by laboratory, histological and immunohistochemical methods.
Keywords: Aristolochic acid; Inflammatory; Immunohistochemical; Immunostaining
ESRD: End Stage Renal Disease; AA: Aristolochic Acid; BUN: Blood Urea Nitrogen; BEN: Bulkan Endemic Nephropathy; PCNA: Proliferating Cell Nuclear Antigen; TIMPS: Tissue Inhibitors of Metalloproteinases
Aristolochic acid (AA) is found in plants of the Aristolochiaceae family, which have been used widely in random recipes for thousands of years to treat asthma, gout, arthritis, pain, hiccough, snake bites, weight loss and slimming [1-3].
Today, it is known that almost all species of the genus aristolochia were considered as human nephrotoxic and carcinogens. This first came to light when cases of nephritis and kidney failure were seen in a group of women in Belgium who had all taken a particular weight-loss product, which contained aristolochic acid [4,5]. After that, more cases have been described worldwide related to exposure to AA [6,7]. In 2001, the FDA issued warnings that herbal products are unsafe if they contain or are suspected to contain aristolochic acid (AA) [8,9].
AAN causes two main distinct health problems. In the upper urinary tract, it induces transitional cell carcinoma, whereas in the kidney it induces cortical tubular atrophy and extensive interstitial fibrosis . However, the exact mechanisms that initiate renal toxicity appear to converge to apoptosis and oxidative stress . In addition, AAN has been shown to present G2/M cell cycle arrest, a pathological feature closely linked to the development of fibrosis . Profibrotic factors such as transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) are upregulated both in vitro and in vivo in the tubulointerstitial cells in aristolochic acid-treated mice, as determined by western blot analysis. These profibrogenic growth factors can stimulate the proliferation and collagen production of fibroblasts .
Therefore, this study was done to prove the effect of aristolochic acid on the kidney and to increase the awareness of its serious effects as a possible cause of ESRD. Also, this study was set up to test our hypothesis about the potential protective role of its withdrawal.
Materials and Methods
This study was conducted on forty five male mice, eight-week-old and weighting (20 - 30 g) were used in this study. The animals were housed in hygienic plastic cages for urine collection before AAI treatment and kept in clean well-ventilated room, with food and water ad-libitum. All animals’ procedures were done according to the recommendation of El-Minia University Ethics committee for proper care and use of experimental animals. Mice were euthanized by ether and euthanized by decapitation, for blood collection.
Animals were randomly assigned to three groups
1. Control group: ten rats received only phosphate-buffered saline at a dose of 6 mg/kg body weight for 3 days according to Schaefer .
2. Aristolochic acid (AA) treated group: fifteen mices were treated with (AA) dissolved in phosphate-buffered saline (purchased from Sigma, St. Louis, MO). i.p in a dose of 3 mg/kg every 3 days for 6 weeks.
3. Remodeling group: fifteen mices were injected with AA i.p. in a dose of 3 mg/kg every 3 days for 6 weeks, followed by 6 weeks remodeling (withdrawal) time.
1. Urine samples: The day before being sacrificed, the animals were placed in metabolic cages for 24 h urine collections. Samples were centrifuged at 4°C for creatinine and urine protein/creatinine ratio. All urine analysis kits were used following manufacturers’ instructions.
2. Blood samples: were collected at sacrifice and were allowed to clot at room temperature, and the serum was separated by centrifugation at 1600×g for 15 min at 4°C and stored at -20°C for estimation of serum creatinine and BUN.
Kidneys were quickly removed at sacrifice and fixed in10% formalin. After fixation, tissues were dehydrated in 96% ethanol and isopropyl alcohol, then embedded in paraffin and cut on a rotation microtome (Leica) in sections with a thickness of 5 to 6 μm, and then stained with hematoxylin & eosin and Masson trichrome stain.
The formalin fixed paraffin embedded sections (5 mm) were attached to poly-L-lysine-pretreated slides (Sigma-Aldrich). After airdrying the paraffin from FFPE, tissue sections were removed (xylene solution). The sections were rehydrated and immersed in a retrieval solution, sodium citrate buffer (pH 6.0); the microwave oven technique was used (650 W, 1 5 min). Phosphate-buffered saline was used for all washing steps.
Endogenous peroxidase activity was quenched with 0.3% hydrogen peroxide in a methanol solution (30 min). Nonspecific protein-binding sites (background staining due to the Fc receptor) were blocked with 20% normal serum (Vectastain Elite ABC kit IgG; Vector Laboratories, Labconsult, Brussels, Belgium) and then with avidin D and biotin solution (avidin/biotin blocking kit; Vector Laboratories, Labconsult).
Subsequently, the sections were incubated overnight with rabbit anti-mouse PCNA (1/4000) monoclonal primary antibody (Abcam, Cambridge, England, UK, ab2426) or with rat monoclonal antibody anti-NEP (1/4000) (Santa Cruz Biotechnology, Boechout, Belgium, sc-80021) and diluted in the blocking buffer. Slides were then incubated with specific biotinylated secondary antibody (Vectastain Elite ABC kit; Vector Laboratories, Labconsult). The extent of the specifically bound primary antibodies was visualized by means of the avidin–biotin peroxidase complex method.
The diaminobenzidine/hydrogen peroxide was used as the chromogene substrate, producing a brown end product. Counterstaining with hematoxylin completed the processing. The specificity of antibodies used was established by the producer. Normal serum (5% solution) instead ofthe primary antibody (used in order to exclude nonspecific staining of kit reagents) showed no staining.
Quantification of immunostainings
Quantifications were performed by Fields containing more than two glomeruli or large vessels were excluded. The patterns of PCNA expression were defined as nuclear staining and was analyzed (40 magnification lens) with a blinded method (AA versus control groups). The PCNA positively stained cells were counted in 30 fields and expressed as an average of positive cells per field.
Compared with control mice, the value of serum creatinine (Figure 1) and urea nitrogen (Figure 2) in AA group were significantly elevated. In the withdrawal group, they were significantly lowered than that of the AA treated group (Table 1).
|AA treated group No.||Control group||Remodelling group No.|
|Day 0||Week 6||Week 12||Day 0||Week 6||Week 12||Day 0||Week 6||Week 12|
|P/C ratio mg/g creatinine||13||852*||------||15||17||18||16||954||98**|
BUN: Blood urea nitrogen. P/C ratio: protein/creatinine ratio mg/g creatinine.
*Significantly different from the baseline at day 0, Also was significantly different from the control group at week 6. **Significantly different at week 12 after 6 weeks of withdrawal.
Table 1: Laboratory Data of the groups throughout the study period.
Hematoxylin and eosin stain: In this study, H&E stained sections of the normal control group showed renal corpuscles formed of tuft of glomeruli, Bowman’s capsule including Bowman’s space, proximal convoluted tubules with narrow lumen, rounded nuclei, apical brush border and basal striations and distal convoluted tubules. The DCTs showed wider lumen and were lined with cubical cells with rounded central nuclei and ill-defined basal striations (Figure 3a).
Figure 3: Photomicrographs of renal tissues showing: a) control group showing: (G), tubules (T) and interstitial matrix (yellow arrow). b) aristolochic acid treated group, there are wide areas of matrix (yellow arrows) with interstitial cellular infiltrate (red arrows). Notice also that some tubules are shrunken and atrophied (yellow astric), others are dilated (yellow pyramid). Tubular cells showed vacuolation, flattening and necrosis (blue arrows). c) AA withdrawal group, the amount of matrix is only slightly more than that in the control group (H&E x400).
On the other hand, examination of sections of AA treated mice showed that some tubules were atrophied collapsed while others were dilated. However, tubular cells exhibited cytoplasmic vacuolation, flattening, necrosis and even shedding. The matrix between tubules was expanded. In the surrounding interstitial areas, mononuclear cell infiltration was observed (Figure 3b). However, withdrawal of AA led to preservation of renal tissue and reduction of tubular damage and cellular infiltrate (Figure 3c).
Masson’s trichrome stain: AA administration in Group 2 led to a marked extracellular matrix deposition around the glomeruli, blood vessels as well as between the tubules (Figure 4b1 and 4b2). The expansion of matrix was significantly decreased after AA withdrawal (Figure 4).
Figure 4: Photomicrographs of kidneys stained with the Masson trichrome stain showing: A) control group showing normal renal tissue: glomeruli (G), tubules (T) and interstitial matrix (yellow arrow). B) aristolochic acid treated group. Notice the presence of wide areas of matrix (yellow arrows) located periglomerular and perivascular in (b1) & between the tubules in (b2) with interstitial cellular infiltrate (red arrows). Notice also that some tubules are atrophied tubules (yellow star), others are dilated (yellow pyramid) with necrotic cells (blue arrows). C) AA withdrawal group, the amount of interstitial collagen is only slightly more than that in the control group (Masson trichrome x 400).
By PCNA immunostaining only few tubular cells expressed PCNA in the control group while in the aristolochic acid (AA) treated mice, the number of immunostained nuclei with PCNA were markedly increased. However, withdrawal of AA resulted in a substantial reduction in number of PCNA-positive cells (Figures 5 and 6).
Figure 5: Representative photomicrographs of proliferating cell nuclear antigen (PCNA) staining in different groups with quantification. In control group, Only few tubular cells expressed PCNA while in the aristolochic acid (AA) treated mice, typical nuclear patterns of PCNA immunostaining were predominantly seen in peritubular areas interstitial cells ( black arrows). Withdrawal of AA in (c) resulted in a substantial reduction of PCNA-positive cells (original magnification x 400).
PCNA-positive nuclei were quantified by counting three highpowered fields at 40x magnification. *Represents statistically significant difference (p<0.05) compared with control mice, **represents statistically significant difference (p<0.05) from AA treated group (Table 2).
|AA treated group No.||Control group||Remodelling group No.|
|Day 0||Week 6||Week 12||Day 0||Week 6||Week 12||Day 0||Week 6||Week 12|
|PCNA positive cells/HPV||19.2||51.1*||------||18.4||19.1||17.3||17.5||49.7||26.2**|
HPF: high power field. *Significantly different from the baseline at day 0 (p<0.05). Also was significantly different from the control group at week 6 (p<0.05). **Significantly different at week 12 after 6 weeks of withdrawal.
Table 2: Changes in PCNA level throughout the experiment.
There is growing evidence that AA plant extracts which is used for curing many diseases, play a causal role in nephropathy. The kidney is the most vulnerable due to its highest blood flow and the high concentration of chemicals in tubular fluid adjacent to tubular cells [15,16].
In this study, we used male laboratory mice because many studies reported that female mice seem to be less sensitive to kidney damage  as female hormone 17β-estradiol (E2) was found to attenuate renal injury .
We found that, the value of serum creatinine and urea nitrogen in AA treated group were significantly elevated compared with control mice. This agrees with other investigators  who recorded increased levels of serum creatinine and BUN, and an elevated urine albumin/ creatinine ratio. In the withdrawal group, after 12 weeks, serum creatinine and BUN were significantly lowered than that of the AA treated group. Other studies recorded that it took a longer period for functional recovery of the kidney to occur, and this is probably due to the fact that recovery from acute kidney injury depends on the dose and duration of exposure [20-22].
Microscopic examination revealed that administration of AA led to tubular atrophy, tubular cells showed necrosis and even detachment leaving a bare basement membrane. The same was observed by other investigators who found that tubular injury leads to tubular atrophy, and eventually end-stage renal failure [23-27].
In this regard, necrosis has been considered one of the mechanisms for aristolochic acid-induced renal injury [28,29] and this was confirmed by the ultrastructural study of Qi, et al.  who found that the epithelium losses many features of its terminally differentiated phenotype where the apical microvilli become effaced; cell height is reduced; the tight junctions lose many of their properties and functions.
Acute renal injury enhanced lysosomal proliferation and induced the autophagy pathway in proximal tubule cells in both animals and human beings . In human kidney biopsies, electron microscopy showed autophagosomes containing organelles such as mitochondria . Autophagy has been shown to be present in both cell-protective and cell death mechanisms to get rid of damaged mitochondria and prevent apoptosis. Several triggers may lead to of protein kinase 3 (PK3) activation, which is the key mediator of necroptosis  as it phosphorylates pseudokinase, which induces plasma membrane rupture .
Moreover, AA can enter the cell via organic anion transporters (OATs) resulting in defective activation of anti-oxidative enzymes, mitochondrial damage [35,36] and impaired regeneration of proximal tubular epithelial cells .
In this research, there was a marked cellular infiltration in the interstitium in AA treated group. Normally, the medulla is completely devoid of leukocytes . In AKI, the tubular epithelial cells generate pro-inflammatory cytokines and molecules responsible for macrophage chemotactic activity. Among them are monocyte chemoattractant peptide-1 (MCP-1) and interleukin-8 (IL-8) and transforming growth factor beta (TGF-β) . Macrophages in turn can produce inflammatory cytokines and enhance type 1 T helper cells immune response [38,39]. Also, tubular epithelial cells express Toll-like receptors, which regulate T-cell activity. In addition to macrophage and T lymphocytes, neutrophils are important contributors to ischemic injury where they enhance production of ROS which in turn directly damage DNA of proximal tubules and augment apoptosis .
Our data indicated that also that kidneys subjected to AA had expanded matrix as demonstrated by massons trichrome stain compared to normal control group. However, in the remodelling group, the amount of collagen in the interstitium was markedly reduced.
The same was observed by Ballhause et al. and Gruia et al. [41,42] who stated that the epithelial cells, as a result of injury, can move into the cell cycle and produce dedifferentiated daughter cells that express increased production of extracellular matrix. They can even undergo epithelial-mesenchymal trans differentiation, migrate from the epithelium, and contribute to the pool of interstitial myofibroblasts [30,40].
Several cytokines secreted by infiltrating macrophages and Tlymphocytes stimulate fibroblast proliferation, and that interstitial fibroblasts produce collagen types I, III, and IV . Moreover, active TGF-β1 is a critical factor involved in tubulointerstitial fibrosis. It increases matrix protein synthesis, inhibits matrix protein degradation, and upregulates integrin matrix adhesion factors . Transforming growth factor-β1 inhibits matrix degradation by increasing the activity of tissue inhibitors of metalloproteinases (TIMPS); and decreasing the activity of metalloproteinases (MMPs) . It also stimulates the synthesis of receptors for extracellular matrix proteins. Furthermore, TGF-β1 is a chemoattractant for fibroblasts  and stimulates their proliferation . However, fibrosis likely develops due to an imbalance between extracellular matrix synthesis and degradation .
By using PCNA immunostaining, we found that the number of PCNA positive cells was observed more frequently in AA treated than in normal control kidneys. According to the literature, glomerular and tubular epithelial cells in normal renal tissue are resting cells lacking the expression of cell proliferation antigen PCNA. After initial injury, histologic indicators of cell proliferation, such as mitosis, hyperchromatic nuclei, and a high nuclear-cytoplasmic ratio are seen. Most injured tubule cells may be replaced through extensive proliferation of neighboring cells, which may be the predominant mechanism of tubular cell injury repair . The increased PCNA expression in tubular epithelial cells and interstitial infiltrates indicates upregulation of their proliferative rate and may be correlated with their proposed role in progression of renal disease [46,47].
Moreover, under certain conditions like renal injury, tubular epithelial cells may be recapturing their fetal proliferation rates which is a property lost during differentiation . However, there was a significant difference between PCNA expression in the remodeling and the control group.
After cessation of AA administration in this study, there was a significant improvement of renal condition as demonstrated by creatinine level, histological and immunohistochemical study. This disagrees with the results of  who found that even after cessation of the exposure, progression of renal failure is generally relentless. However, acute AAN may progress to ESRD within 1 month in patients having continuously ingesting a high dose during a short period of time  or in cases of either a consistent or intermittent intake of a low dose of AA for a long period of time . Anyhow, we are concerned that this form of nephropathy may become more common in the future because of the continuous online trading of random therapeutic recipes containing AA. Furthermore, they are often bundled and sold as formulations rather than individually. To complicate matters, these products are sometimes not registered and improperly labeled, making it difficult for suppliers and consumers to be certain of its constituents [4,51]. Indeed, the web is a marketing tool with low barriers to entry and the disaster is that anyone can set up a web site inexpensively .
This study confirmed that aristolochic acid is nephrotoxic as evidenced by laboratory, histological and immunohistochemical methods. It also confirmed that cessation of administration of AA leads to reduction of its toxic effect on kidney.
Recommendations: We recommend that this thesis should be translated to Arabic language to increase awareness of people who use slimming herbs and to draw the attention of doctors to collect histories of herbal medication from patients as a routine clinical practice. We also recommend that herbal substances should be subject to the same strict scrutiny and controls as drugs. Lastly, we appeal to health officials to take the necessary measures to prevent trading random therapeutic recipes through social media to prevent kidney disease. Otherwise, it may cause serious complications to users that may reach death.
- Mantle P, Modalca M, Nicholls A, Tatu C, Tatu D, et al. (2011) Comparative HNMR metabolomic urine analysis of people diagnosed with Balkan endemic nephropathy, and healthy subjects, in Romania and Bulgaria: A pilot study. Toxins (Basel) 3: 815-833.
- Turesky R, Yun B, Brennan P, Mates D, Jinga V, et al. (2016) Aristolochic acid exposure in Romania and implications for renal cell carcinoma. Br J Cancer 114: 76-80.
- Jadot I, Declèves AE, Nortier J, Caron N (2017) An integrated view of aristolochic acid nephropathy: update of the literature. Int J Mol Sci 18: E297.
- Stiborová M, Arlt VM, Schmeiser HH (2016) Balkan endemic nephropathy: An update on its aetiology. Arch Toxicol 90: 2595-2615.
- Hoang M, Chen C, Chen P, Roberts N, Dickman K, et al. (2016) Aristolochic acid in the etiology of renal cell carcinoma. Cancer Epidemiol Biomark Prev 25: 1600-1608.
- Chan W, Pavlović N, Li W, Chan C, Liu J, et al. (2016) Quantitation of aristolochic acids in corn, wheat grain and soil samples collected in Serbia: Identifying a Novel Exposure Pathway in the Etiology of Balkan Endemic Nephropathy. J Agric Food Chem 64: 5928-5934.
- Abdullah R, Diaz L, Wesseling S, Ivonne M, Rietjens M (2017) Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach. Food Additives and Contaminants: Part A 34: 135-144.
- Ping T, Tong Z, Fang Y, Na L, Ju L (2005) Pharmacokinetics of aristolochic acid A in Radix Aristolochiae and Guanxinsuhe capsule. Chinese Traditional and Herbal Drugs 36: 1671-1674.
- Yun B, Sidorenko V, Rosenquist T, Dickman K, Grollman A, et al. (2015) New approaches for biomonitoring exposure to the human carcinogen aristolochic acid. Toxicol Res 4: 763-776.
- Gokmen M, Cosyns J, Arlt V (2013) The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med 158: 469.
- Mantle P, Herman D, Tatu C (2016) Is Aristolochic Acid Really the Cause of the Balkan Endemic Nephropathy? Journal of Controversies in Biomedical Research 2: 9-20.
- Jelakovic B, Karanovic S, Vukovic-Lela I (2012) Aristolactam DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 81: 559-567.
- Yang L, Besschetnova T, Brooks C, Shah J, Bonventre J (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543.
- Schaefer MR (2016) Non-transgenic mouse models of kidney disease experimental Nephrology and Genetics. Review Nephron 133: 53-61.
- Dickman K, Sweet D, Bonala R, Ray T, Wu A (2011) Physiological and molecular characterization of aristolochic acid transport by the kidney. J Pharmacol Exp Ther 338: 588-597.
- Benjamin A, Patrick V, Verhulst H (2017) Environmental toxin-induced acute kidney injury. Clinical Kidney Journal 10: 747-758.
- Hu H, Wang G, Batteux F, Nicco C (2009) Gender differences in the susceptibility to renal ischemia-reperfusion injury in BALB/c mice. Tohoku J Exp Med 218: 325-329.
- Shi M, Ma L, Zhou I, Fu P (2016) Renal protective effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy Molecules 21: E1391.
- Liguori G, Belfiore P, Amora M, Liguori R, Plebani M (2017) The principles of health technology assessment in laboratory medicine. Clin Chem Lab Med 55: 32-37.
- Plebani M (2017) Biomarkers of acute kidney injury: a step forward. Clin Chem Lab Med 55: 05-09.
- Kashani K, Cheungpasitporn W, Ronco C (2017) Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med 55: 1074-1089.
- Ioannidis J, Bossuyt P (2017) Waste, leaks, and failures in the biomarker pipeline. Clin Chem 63: 963-972.
- Bhattacharjee P, Bhattacharyya D (2013) Characterization of the aqueous extract of the root of Aristolochia Indica: Evaluation of its traditional use as an antidote for snake bites. Journal of Ethnopharmacology 145: 220-226.
- Zhou D, Liu Y (2016) Renal fibrosis in 2015: understanding the mechanisms of kidney fibrosis. Nature Reviews Nephrology 12: 68-70.
- Luciano R, Perazella M (2015) Aristolochic acid nephropathy: Epidemiology, clinical presentation, and treatment. Drug Safety 38: 55-64.
- Lin C, Chang W, Lee J, Chang T, Huang Y, et al. (2017) Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method Biomedical Chromatography 32: e4127.
- Moeckel G (2018) Pathologic perspectives on acute tubular injury assessment in the kidney biopsy seminars in nephrology, 38: 21-30.
- Pozdzik A, Salmon I, Husson C (2008) Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant 23: 2480-2491.
- Stengel B (2010) Chronic kidney disease and cancer: A troubling connection. J Nephrol 23: 253-262.
- Qi X, Cai Y, Gong L (2007) Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid. Toxicol Appl Pharmacol 222: 105-110.
- Sica V, Jose L, Pedro M, Izzo V, Maiuri M, et al. (2015) Organelle-specific initiation of autophagy. Molecular Cell 59: 522-539.
- Takabatake Y, Kimura T, Takahashi A, Isaka Y (2014) Autophagy and the kidney: health and disease. Nephrology Dialysis Transplantation, 291: 1639-1647.
- He S, Wang L, Miao L, Wang T, Du F, et al. (2009) Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α. Cell 137: 1100-1111.
- Baehrecke E (2005) Autophagy: dual roles in life and death? Nature Reviews Molecular Cell Biology 6: 505-510.
- Zhou Y, Bian X, Fang L, He W, Dai C, et al. (2013) Aristolochic acid causes albuminuria by promoting mitochondrial DNA damage and dysfunction in podocyte. PLoS One 8: e83408.
- Stallons L, Whitaker R, Schnellmann R (2014) Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis. Toxicol Lett 224: 326-332.
- Wu C, Yang M, Zhou Z, Feng X, Zhong X, et al. (2015) Urinary soluble intercellular adhesion molecule-1 and vascular cellular adhesion molecule-1: potential biomarkers of active lupus nephritis. Journal of Thouthern Medical University 35: 1272-1276.
- Schrezenmeier EJ, Budde K (2017) Biomarkers in acute kidney injury-pathophysiological basis and clinical performance. Acta Physiol 219: 554-572.
- Feng Y, Ren J, Gui Y, Wei W, Shu B (2017) Wnt/β-catenin-promoted macrophage alternative activation contributes to kidney fibrosis. JASN 29: 182-193.
- Man Y, Rui H, Chen Y, Wang G, Sun L, et al. (2017) Aristolochic acid-induced autophagy promotes epithelial-to-myofibroblast transition in human renal proximal tubule epithelial cells. Evidence-Based Complementary and Alternative Medicine.
- Ballhause TM, Soldati R, Mertens PR (2014) Sources of myofibroblasts in kidney fibrosis: all answers are correct, however to different extent. International Urology and Nephrology 3: 659-664.
- Gruia A, Gazinska P, Herman D, Ordodi V, Tatu C (2015) Revealing a pre-neoplastic renal tubular lesion by p-S6 protein immunohistochemistry after rat exposure to aristolochic acid. J Kidney Cancer VHL 2: 153-162.
- Xu X, Chai J, Chen Y, Rui H, Wang Y (2016) Hirsutella sinensis attenuates aristolochic acid-induced renal tubular epithelial-mesenchymal transition by inhibiting TGF-β1 and snail expression. PLoS One 11: e0149242.
- He Y, Wang X, Bu Y, Song Y (2016) The impact of genetic variants in matrix metalloproteinase-9 gene on lupus nephritis in Chinese Han population. Int J Clin Exp Pathol 9: 3919-3924.
- Tveita A, Rekvig O, Zykova S (2008) Increased glomerular matrix metalloproteinase activity in murine lupus nephritis. Kidney Int 74: 1150-1158.
- Kubben F, Haesevoets P, Engels L, Baeten C, Schutte B (1994) Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation Gut 35: 530-535.
- Nakopouloul K, Stefanakil K, Salpigidis J, Boletis J, Papadakis PM (1997) The value of proliferating cell nuclear antigen (PCNA)/cyclin in the assessment of cell proliferation in glomerulonephritis. Histol Histopathol 12: 655-662.
- Stiborová M, Arlt V, Schmeiser H (2017) DNA adducts formed by aristolochic acid are unique biomarkers of exposure and explain the initiation phase of upper urothelial cancer. Int J Mol Sci 18: E2144.
- Nortier J, Pozdzik A, Roumeguere T, Vanherweghem J (2015) Aristolochic acid nephropathy (Chinese herb nephropathy). Nephrol Ther 11: 574-588.
- Gökmen M, Cosyns J, Arlt V, Stiborová M, Phillips D (2013) The epidemiology, diagnosis, and management of aristolochic acid nephropathy: A narrative review. Ann Intern Med 158: 469-477.
- Decleves A, Jadot I, Colombaro V, Martin B, Voisin V (2016) Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets. Exp Physiol 101: 193-206.
- Grollman AP, Marcus DM (2016) Global hazards of herbal remedies: lessons from Aristolochia: The lesson from the health hazards of Aristolochia should lead to more research into the safety and efficacy of medicinal plants. EMBO reports 17: 619-625.
Citation: Hamouda AHA, Taha HA, Ahmad RF (2018) Study of the Effect of Aristolochic Acid on Mice Kidney and the Effect of Withdrawal: Histological and Immunohistochemical Study. J Cytol Histol 9: 504. Doi: 10.4172/2157-7099.1000504
Copyright: © 2018 Hamouda AHA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
4th International Conference on Cytopathology & Histopathology Theme: Innovation and future trends of Cytopathology
August 29-30, 2018 Boston | Massachusetts | USA
- Total views: 141
- [From(publication date): 0-2018 - May 27, 2018]
- Breakdown by view type
- HTML page views: 119
- PDF downloads: 22